Capital International Investors
GPCR icon

Capital International Investors’s Structure Therapeutics GPCR Stock Holding History

Capital International Investors’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,618,876
Closed -$33.6M – 458
2025
Q2 		$33.6M Sell
1,618,876
-150
-0% -$3.3K 0.01% 361
2025
Q1 		$28M Sell
1,619,026
-55
-0% -$1.35K 0.01% 371
2024
Q4 		$43.9M Buy
1,619,081
+103,059
+7% +$3.66M 0.01% 348
2024
Q3 		$66.5M Buy
1,516,022
+17,378
+1% +$672K 0.01% 301
2024
Q2 		$58.9M Buy
1,498,644
+217,080
+17% +$8.91M 0.01% 302
2024
Q1 		$54.9M Buy
1,281,564
+431,540
+51% +$18.2M 0.01% 321
2023
Q4 		$34.6M Buy
+850,024
New +$48.7M 0.01% 351

Other funds holding GPCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Capital International Investors's GPCR Position: Q3 2025 in Review

Capital International Investors sold out of Structure Therapeutics (GPCR) in Q3 2025, closing a stake of 1,618,876 shares — an estimated $33.6M sold.

Capital International Investors first reported a position in GPCR in Q4 2023 and held it in 7 quarters. The position peaked at $66.5M in Q3 2024. 156 funds tracked by Wall St. Rank hold GPCR as of Q3 2025.

  • Capital International Investors reported no remaining Structure Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Capital International Investors sold 1,618,876 Structure Therapeutics shares in Q3 2025, an estimated $33.6M.
  • Capital International Investors first reported a position in Structure Therapeutics in Q4 2023 and held it in 7 quarters.
  • Capital International Investors's Structure Therapeutics position peaked at $66.5M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2025.

Based on Capital International Investors's 13F filing for Q3 2025, filed 13 Nov 2025.